Skip to search formSkip to main contentSkip to account menu

atreleuton

Known as: ((R)-3-(5-(p-Fluorobenzyl)-2-thienyl)-1-methyl-2-propynyl)-1-hydroxyurea, N-(3-(5-((4-fluorophenyl)methyl)-2-thienyl)-1-methyl-2-propynyl)-N-hydroxyurea 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (2)

ABT 761VIA 2291

Broader (2)

Lipoxygenase Inhibitorshydroxyurea
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Title Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 ( atreleuton ) on coronary plaque progression : a serial CT angiography study Permalink
2012
2012
Abstract 12548: 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) Treatment Decreases Epicardial and Pericardial Adipose Tissue in Patients with Recent Acute Coronary Syndrome
Background: Epicardial adipose tissue (EAT) has been shown to be associated with coronary atherosclerosis and also as a predictor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)